Cytophage Technologies Ltd. Stock Price

TSXV:CYTO Community·CA$13.0m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

CYTO Share Price Performance

CA$0.20

-0.08 (-28.57%)

CA$0.20

-0.08 (-28.57%)

CA$0.20

Thu, 6 Nov 25

Share PriceCA$0.20

CYTO Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks

0 Rewards

View Full Analysis

Cytophage Technologies Ltd. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.075
: 0%
: 0%
: 0%

View Full Analysis

About CYTO

Founded: n/a
Employees: n/a
CEO: Steven Theriault
WebsiteView website: cytophage.com

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada.